Published in J Steroid Biochem Mol Biol on August 01, 1993
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. J Med Chem (1980) 0.86
[Antimicrobial and tumor-inhibiting properties of dithiourethane and studies on the mechanism of action. 16. Cytostatica]. Pharmazie (1972) 0.85
Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem (1988) 0.85
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol (1995) 0.84
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. J Med Chem (1982) 0.80
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II--The antileukemic effect. Arch Pharm (Weinheim) (1989) 0.79
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes. J Cancer Res Clin Oncol (1991) 0.78
[Synthesis of 14C-anpirtoline]. Arch Pharm (Weinheim) (1988) 0.78
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3. Arch Pharm (Weinheim) (1992) 0.78
[The mode of local anesthetic action of cinchocaine homologues]. Arzneimittelforschung (1970) 0.78
A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol (1994) 0.78
Benzylamines: synthesis and evaluation of antimycobacterial properties. J Med Chem (1984) 0.77
Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res (1991) 0.77
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part I--The antibacterial effect. Arch Pharm (Weinheim) (1989) 0.77
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer. J Cancer Res Clin Oncol (1993) 0.77
Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes. Arch Pharm (Weinheim) (1993) 0.76
[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity. Prostate (1989) 0.76
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation. Cancer Chemother Pharmacol (1992) 0.76
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative. J Cancer Res Clin Oncol (1998) 0.76
N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity. J Med Chem (1982) 0.76
[Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)]. J Cancer Res Clin Oncol (1980) 0.76
Development of a parenterally administrable hydrosol preparation of the "third generation platinum complex" [(+/-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and studies on the stability and antitumor activity. Arch Pharm (Weinheim) (1995) 0.75
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. J Med Chem (1984) 0.75
Synthesis and evaluation of catechol analogs of diethylstilbestrol on a hormone-dependent human mammary carcinoma implanted in nude mice. J Cancer Res Clin Oncol (1982) 0.75
[The effect of the culture medium on the testing of antimycobacterial compounds]. Arch Pharm (Weinheim) (1989) 0.75
[Antimycobacterial effect of N-alkylbenzylamines]. Pharmazie (1977) 0.75
Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes. J Med Chem (1986) 0.75
The tumor-inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1984) 0.75
[Comparative studies on the antimicrobial effect of tertiary and quartenary beta-aminoketones]. Pharmazie (1970) 0.75
[Configurative assignment of the diastereomer N,N'-dialkyl- , '-diphenylethylenediamines by nucleic resonance spectroscopy. 19. Cytostatics]. Arzneimittelforschung (1972) 0.75
Mammary tumor inhibiting effect of 3,3'-diacetoxy-alpha, beta-dialkylstilbenes and of related stilbene oxides. J Med Chem (1982) 0.75
[The working mechanism of local anesthetics. 8. Preparation of enantiomer N-phthalylamino carbonic acids]. Pharmazie (1976) 0.75
[Synthesis of 1-aryl-1-amino-alkynes-2 with cholinergic and cholinolytic properties. 10. Reactions of alpha-aminonitriles]. Arzneimittelforschung (1972) 0.75
[Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)]. Arch Pharm (Weinheim) (1980) 0.75
[Studies on the antimicrobial and tumor-inhibiting properties of N-analogous stilbestrols. 15. Cytostatica]. Arch Pharm (Weinheim) (1972) 0.75
Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes. J Med Chem (1981) 0.75
[Syntheses and evaluation of the potentially oestrophilic cytostatics 2,3-epoxy-3,4-bis-(4-acetoyphenyl)-4-hexene and 2,3,4,5-bisepoxy-3,4-bis-(4-acetoxyphenyl)hexane (author's transl)]. Arch Pharm (Weinheim) (1982) 0.75
[Azomethines and oxazolidines from norfenefrine. Development of compounds with prolonged action and blood pressure increasing effect]. Arch Pharm (Weinheim) (1975) 0.75
[Relations between physical-chemical properties and antimicrobial effect of beta-amino-ketones. 9. Cytostatics]. Arzneimittelforschung (1970) 0.75
[The effect of meso- and racemic-N,N'-dibutyl- , '-di-(3-chloro-4-methoxyphenyl)-ethylenediamine on 7,12-dimethylbenz-( )-anthracene induced mammary tumor of the Sprague-Dawley rat. 14. Cytostatic agents]. Arzneimittelforschung (1971) 0.75
[Mechanism of action of cis-bis(glycylglycine ethyl ester)platinum(II) chloride--effect on protein biosynthesis]. Arch Pharm (Weinheim) (1983) 0.75
Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1988) 0.75
[Studies on the mechanism of action of local anesthetics. 6. Binding of local anesthetics of complementary membranes structures]. Pharmazie (1972) 0.75
Development of selectively acting platinum complexes. Cancer Treat Rev (1984) 0.75
[The antineoplastic action of o-substituted [1,2-bis(4-hydroxyphenyl)-ethylenediamine]dichloroplatinum (II) complexes and their methylethers]. Arch Pharm (Weinheim) (1988) 0.75
[Studies on the mammary tumor inhibiting effect of cis-dichlorobis(glycylglycinethylester)platinum(II) (author's transl)]. Arch Pharm (Weinheim) (1981) 0.75
Effect of estrophilic platinum complex on the mouse uterus. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.75
[Relations between physico-chemical properties and antimicrobial activity of beta-aminoketones. 10. Cytostatic compounds]. Arzneimittelforschung (1971) 0.75
[Antimicrobial and tumor-inhibiting effects of Mannich bases of the 3,3'-and 4,4'-dihydroxy- , -diethylstilben]. Arch Pharm (Weinheim) (1972) 0.75
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat. J Cancer Res Clin Oncol (1982) 0.75
Design of metallocenic drugs. IARC Sci Publ (1986) 0.75
[Studies on the mechanism of action of local anesthetics. 1. Theories, problems and solution possibilities]. Pharmazie (1972) 0.75
[Carcinostatic and antimicrobial activity of acylated N-hemiacetals, aminals and aminomethyl esters of dithiocarbamic acid. 18. Cytostatics]. Arch Pharm (Weinheim) (1972) 0.75
[Antimycobacterial N-alkylbenzylamines: synthesis and testing of 4-aminomethyl-2-hydroxybenzoic acid and its homologs]. Arch Pharm (Weinheim) (1982) 0.75
[N-(4-hydroxyphenyl)-N-(1,1,1-trifluor-2-propyl)-4-hydroxyben zamide: synthesis and pharmacologic evaluation of a new antiestrogen]. Arch Pharm (Weinheim) (1988) 0.75
[Investigations of pharmacokinetics and metabolic behavior of N-L-pnenylalanyl-L-2-amino-1-phenylpropane (author's transl)]. Arzneimittelforschung (1981) 0.75
[The mode of action of local anesthetics. 7. Synthesis of enantiomeric N-aminoacyl-2.6.-dimethylaniline, -benzylamine and-2-phenylethylamine]. Pharmazie (1976) 0.75
[Relations between structure and antitumor activity of cis-dichloro[bis(oligopeptide-ester)]platinum(II) complexes]. Arch Pharm (Weinheim) (1983) 0.75
[Synthesis of antimicrobial effective dithiourethanes. 12. Cytostatics]. Pharmazie (1970) 0.75
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II)-complexes, Part II: Biological properties. Arch Pharm (Weinheim) (1989) 0.75
[Antitumor activity of cis-dichloro-bis-(alpha-amino acid ester)platinum complexes]. Arch Pharm (Weinheim) (1983) 0.75
A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay. J Cancer Res Clin Oncol (1988) 0.75
[Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols. J Med Chem (1984) 0.75
[Pharmacology of potential antidepressants of the N-L-phenylalanyl-beta-phenylalkylamine class]. Arzneimittelforschung (1983) 0.75
[Synthesis and local anesthetic effect of N-piperidino-methyl-4-alkoxybenzamides]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
[Experimental chemotherapy of mammary neoplasms. A review]. Pharmazie (1976) 0.75
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 1. Synthesis and estrogen receptor binding affinity of 2,2'- and 3,3'-disubstituted hexestrols. J Med Chem (1983) 0.75
[The relationship between structure and tuberculostatic effect in the benzylamine group]. Pharmazie (1976) 0.75
[Cis-dichloro(bis(oligopeptide ester))platinum (II) complexes: studies on the demonstration of their antitumor action with a bacteriological test system]. Arch Pharm (Weinheim) (1984) 0.75
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. J Cancer Res Clin Oncol (1982) 0.75
[Studies on the mechanism of action of local anesthetics. 2. Demonstration of the different effect of enantiomeric local anesthetics]. Pharmazie (1972) 0.75
N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. J Med Chem (1980) 0.75
[Intraocular lenses - aphorisms of an operating practitioner (author's transl)]. Klin Monbl Augenheilkd (1979) 0.75
[The mode of action of antimycobacterial benzylamines]. Arch Pharm (Weinheim) (1989) 0.75
[Conversions of aliphatic substituted alpha-aminonitriles with metallic sodium in toluol. VI. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[The action mechanisms of local anesthetics. 9. N-aminoacyl-beta-phenylalkylamine tested for development of antidepressive agents from psychotonics]. Pharmazie (1976) 0.75
Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane. Arch Pharm (Weinheim) (1990) 0.75
[Activity of cis-bis(glycylglycine ethyl ester)platinum(II) chloride-effects on nucleic acid metabolism]. Arch Pharm (Weinheim) (1983) 0.75
[Reactions of -aminonitriles with alkinyl- and alkyl-Grignard compounds. IX. Reactions of -aminonitriles]. Arch Pharm (Weinheim) (1972) 0.75
Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane. J Cancer Res Clin Oncol (1989) 0.75
Carrier mediated action of platinum complexes on estrogen receptor positive tumors. Eur J Cancer Clin Oncol (1989) 0.75
The tumor-inhibiting effect of diethylstilbestrol-3,4-oxide. J Cancer Res Clin Oncol (1981) 0.75
Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer. J Cancer Res Clin Oncol (1989) 0.75
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]. Arch Pharm (Weinheim) (1990) 0.75
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)-compl exe s, Part I: Synthesis. Arch Pharm (Weinheim) (1989) 0.75
[Studies on the mechanism of action of local anesthetic agents. 3. Relations between solubility of lipids and biological effect in homologous local anesthetic agents]. Pharmazie (1972) 0.75
Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties. J Med Chem (1985) 0.75
[Synthesis of hexestrol-isostereo meso-N,N'-dimethyl-alfa,alfa'-di(4-hydroxyphenyl)-ethylenediamine]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
[14C-labeling of D 16,427, a new positive inotropic agent]. Arch Pharm (Weinheim) (1986) 0.75
Anticancer drugs: estrophilic cisplatin derivatives. Cancer Treat Rev (1987) 0.75
[Antineoplastic effect of N,N',N''-trihydroxymethylmelamine and analogous compounds. 23. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
[Synthesis of spasmolytic N-diphenylacetamidomethyl-dimethylalkyl-ammonium iodides]. Arch Pharm (Weinheim) (1972) 0.75
[Synthesis and pharmacological test of N-(3'-methoxy-benzamidomethyl)-D-norephedrine and Analogous Compounds (author's transl)]. Arch Pharm (Weinheim) (1976) 0.75